Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Driving treatment for females with X-linked adrenoleukodystrophy.

Molecular genetics and metabolism·2026

Same author

Neuroradiological patterns and prognostic implications in type I Alexander disease.

Molecular genetics and metabolism·2026

Same author

Normative modeling for quantitative brain MRI phenotyping and biomarker discovery for pediatric leukodystrophies.

medRxiv : the preprint server for health sciences·2026

Same author

Addressing the needs of nano-rare patients: the n-Lorem experience.

Nucleic acids research·2026

Same author

Developmental trajectory of individuals with Pelizaeus-Merzbacher Disease (PMD).

Molecular genetics and metabolism·2026

Same author

Author Correction: Biallelic variants in the noncoding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes.

Nature genetics·2026

Same journal

Fetal and Perinatal Brain MRI Findings in Adaptor Protein Complex 4-Associated Hereditary Spastic Paraplegia.

Annals of the Child Neurology Society·2026

Same journal

Epilepsy Phenotypic Spectrum of NUS1-Related Disorder: A Case Series.

Annals of the Child Neurology Society·2026

Same journal

Not Just Half a Doctor: Promoting Humanism During Stressful Times.

Annals of the Child Neurology Society·2026

Same journal

The use of synaptic extracellular myo-inositol to treat Developmental and Epileptic Encephalopathy.

Annals of the Child Neurology Society·2025

Same journal

Symptom Onset in Classic Rett Syndrome: Analysis of Initial Clinical Severity Scale Entries.

Annals of the Child Neurology Society·2025

Same journal

Increased Extra-Axial Cerebrospinal Fluid Volume in Children with Angelman Syndrome: Links to Sleep Problems and Seizures.

Annals of the Child Neurology Society·2025

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 10, 2025

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

Clinically Important Endpoints in Individuals With Leukodystrophy: A Multisite Study.

Emma R Kotes¹, Sarah Woidill¹, Russell D'Aiello²

¹Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Annals of the Child Neurology Society

|August 26, 2025

Summary

This summary is machine-generated.

Leukodystrophy complications like feeding tube placement are common and vary by diagnosis. Severity of motor impairment, not just diagnosis, predicts adverse events in these rare neurological disorders.

More Related Videos

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

Related Experiment Videos

Last Updated: Sep 10, 2025

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

Area of Science:

Neurology
Genetics
Rare Diseases

Background:

Leukodystrophies are rare genetic disorders affecting central nervous system myelination, leading to diverse neurological impairments.
These conditions present with significant variability in severity and are associated with secondary complications like scoliosis and feeding difficulties.
Current care guidelines may not fully address the spectrum of complications across all leukodystrophy types.

Purpose of the Study:

To analyze real-world data on complications in leukodystrophies to inform evidence-based care guidelines.
To identify patterns and predictors of health events in a large cohort of patients with various leukodystrophies.

Main Methods:

A cross-sectional observational study utilizing electronic health records (EHR) from a leukodystrophy research consortium.
1203 subjects with 42 types of leukodystrophies were identified across five hospital systems.
Data collected included time-to-event for complications (orthopedic, feeding, respiratory, urinary) and maximum motor milestones.

Main Results:

Feeding tube placement was the most frequent complication; median time to first complication varied significantly between disorders.
Specific leukodystrophy diagnoses correlated with maximum gross motor milestone attainment.
When stratified by motor function severity, the frequency of adverse events was significantly associated with functional status.

Conclusions:

Real-world data from EHRs can effectively identify medical events across institutions for rare diseases like leukodystrophies.
Health event rates and motor milestone attainment differ by leukodystrophy type, but motor function severity is a key predictor of complications.
Findings support developing comprehensive care models for leukodystrophies stratified by motor function and highlight the value of integrated EHR analysis.